Bristol Myers Squibb
Biotech Investor · 7 portfolio companies
Portfolio
7
Combined Value
$413.9M
Focus Areas
7
Top Stage
Phase 1
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Century Therapeutics | $413.9M |
| Alloy Therapeutics | — |
| JW Therapeutics | — |
| Accent Therapeutics | — |
| NeoPhore | — |
| Be Biopharma | — |
| ArsenalBio | — |